RICHMOND, Va.--(BUSINESS WIRE)--Insmed Inc. (Nasdaq:INSM), a biopharmaceutical company with unique protein process development and manufacturing experience and a proprietary protein platform aimed at niche markets with unmet medical needs, today announced results for the third quarter and nine-month period ended September 30, 2007.
